1. Home
  2. RUN vs AAPG Comparison

RUN vs AAPG Comparison

Compare RUN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RUN
  • AAPG
  • Stock Information
  • Founded
  • RUN 2007
  • AAPG 2009
  • Country
  • RUN United States
  • AAPG China
  • Employees
  • RUN N/A
  • AAPG N/A
  • Industry
  • RUN Industrial Machinery/Components
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • RUN Miscellaneous
  • AAPG Health Care
  • Exchange
  • RUN Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • RUN 3.7B
  • AAPG 3.6B
  • IPO Year
  • RUN 2015
  • AAPG 2025
  • Fundamental
  • Price
  • RUN $19.93
  • AAPG $32.00
  • Analyst Decision
  • RUN Buy
  • AAPG Strong Buy
  • Analyst Count
  • RUN 19
  • AAPG 3
  • Target Price
  • RUN $20.41
  • AAPG $49.00
  • AVG Volume (30 Days)
  • RUN 8.2M
  • AAPG 7.7K
  • Earning Date
  • RUN 11-06-2025
  • AAPG 11-19-2025
  • Dividend Yield
  • RUN N/A
  • AAPG N/A
  • EPS Growth
  • RUN N/A
  • AAPG N/A
  • EPS
  • RUN N/A
  • AAPG N/A
  • Revenue
  • RUN $2,316,656,000.00
  • AAPG $54,524,554.00
  • Revenue This Year
  • RUN $11.35
  • AAPG N/A
  • Revenue Next Year
  • RUN $9.26
  • AAPG $368.64
  • P/E Ratio
  • RUN N/A
  • AAPG N/A
  • Revenue Growth
  • RUN 13.79
  • AAPG N/A
  • 52 Week Low
  • RUN $5.38
  • AAPG $16.50
  • 52 Week High
  • RUN $22.44
  • AAPG $48.45
  • Technical
  • Relative Strength Index (RSI)
  • RUN 50.94
  • AAPG 41.98
  • Support Level
  • RUN $15.92
  • AAPG $30.93
  • Resistance Level
  • RUN $21.34
  • AAPG $34.31
  • Average True Range (ATR)
  • RUN 1.40
  • AAPG 0.81
  • MACD
  • RUN -0.23
  • AAPG 0.06
  • Stochastic Oscillator
  • RUN 64.18
  • AAPG 48.79

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: